SIGLEC9 is highly expressed in cervical cancer and linked to poor prognosis.

Bioinformatics show SIGLEC9 correlates with macrophages and T-cells.

SIGLEC9+ TAMs and T-cells are highly enriched in the cervical cancer microenvironment.

High SIGLEC9+ TAM expression correlates with poor prognosis in cervical cancer.

Prematurity is a risk factor for lifelong hearing damage.

Hearing monitoring is necessary until around 3-years of age.

Hearing monitoring after peri-intraventricular hemorrhage is essential.

Establishes the first cephalic index standards for multi-ethnic Malaysian subadults.

Reports a negative correlation between age and CI, with a decline of 0.026 yearly.

Shows higher CI values in Malaysians than in Caucasians and other Asian groups.

Provides a validated tool (ICC > 0.93) to track cranial growth and deformity severity.

Two diagnostic criteria diagnose cancer cachexia in HNSCC patients.

Disease-free HNSCC patients present cancer cachexia after long-term follow-up.

Cachexia is not associated with dysphagia.

Uterine carcinosarcoma is treated with no histology-based management.

Heterologous sarcomatous component has a negative impact on overall survival.

First study to report a negative prognostic impact in FIGO I‒IVA in Latin America.

There is a need to reconsider the role of sarcomatous component to tailor treatment.

Fibromyalgia patients have thinner skin on ultrasound.

Trapezius muscle is thicker and stiffer in fibromyalgia.

Muscle stiffness is correlated with pain severity.

Reduced skin thickness may drive peripheral sensitization.

Uterine carcinosarcoma is treated with no histology-based management.

Heterologous sarcomatous component has a negative impact on overall survival.

First study to report a negative prognostic impact in FIGO I-IVA in Latin America.

There is a need to reconsider the role of the sarcomatous component to tailor treatment.

CRP shows high sensitivity but low specificity for adult sepsis diagnosis.

Diagnostic accuracy of CRP in sepsis is limited by high heterogeneity.

Prognostic value of CRP for mortality in sepsis remains uncertain.

False-positive rate of CRP in sepsis diagnosis reaches about 44 %.

Overall quality of evidence on CRP use in sepsis is low.